The light chain of neurofilaments (Nf-L) is one of the most widely investigated fluid biomarkers in the context of parkinsonism, showing modestly increased peripheral levels in PD patients compared to healthy controls (HC) and a markedly pronounced elevation in atypical parkinsonian syndromes compared to PD [8–10]. Here, NEFL is linked to Parkinson disease.